Pharmacodynamic and pharmacokinetic study of propranolol in patients with cirrhosis and portal hypertension.-Reference-Cited by-同舟云学术

Pharmacodynamic and pharmacokinetic study of propranolol in patients with cirrhosis and portal hypertension.

Published:1989-06 Issue:6 Volume:27 Page:763-770
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:British Journal of Clinical Pharmacology

Author:

Cales P,Grasset D,Ravaud A,Meskens C,Blanc M,Vinel JP,Cotonat J,Pascal JP

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2125.1989.tb03438.x/fullpdf

Reference27 articles.

1. β-adrenoceptor blocking activity and duration of action of pindolol and propranolol in healthy volunteers;Aellig;Br. J. clin. Pharmac.,1976

2. Pharmacology of propranolol in patients with cirrhosis and portal hypertension;Arthur;Gut,1985

3. Intrinsic hepatic clearance and Child-Turcotte classification for assessment of liver function in cirrhosis;Barbare;J. Hepatol.,1985

4. Etude des parametres de biodisponibilite du propranolol chez des malades cirrhotiques, apres administration orale de la forme retard;Blanc;Therapie,1987

5. A study of factors influencing drug disposition in chronic liver disease, using the model drug (+)-propranolol;Branch;Br. J. clin. Pharmac.,1976

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring mutation specific beta blocker pharmacology of the pathogenic late sodium channel current from patient-specific pluripotent stem cell myocytes derived from long QT syndrome mutation carriers;Channels;2022-08-10

2. Primary prevention of variceal bleeding in people with oesophageal varices due to liver cirrhosis: a network meta-analysis;Cochrane Database of Systematic Reviews;2021-04-06

3. Development and Evaluation of a Physiologically Based Pharmacokinetic Drug-Disease Model of Propranolol for Suggesting Model Informed Dosing in Liver Cirrhosis Patients;Drug Design, Development and Therapy;2021-03

4. Non‐selective beta‐blockers increase overall and liver mortality in alcoholic cirrhosis with MELD ≥ 12 over 5 years of follow‐up;Liver International;2020-12-29

5. Clinical Pharmacokinetics of Propranolol Hydrochloride: A Review;Current Drug Metabolism;2020-06-11